Short Interest in Jaguar Health, Inc. (NASDAQ:JAGX) Rises By 49.7%

Jaguar Health, Inc. (NASDAQ:JAGX) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 953,100 shares, a growth of 49.7% from the February 13th total of 636,700 shares. Approximately 7.6% of the company’s stock are short sold. Based on an average daily volume of 471,800 shares, the days-to-cover ratio is currently 2.0 days.

Jaguar Health Trading Down 0.9 %

Shares of Jaguar Health stock traded down $0.00 during trading on Friday, reaching $0.45. The stock had a trading volume of 305,925 shares, compared to its average volume of 409,586. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. Jaguar Health has a 52 week low of $0.42 and a 52 week high of $21.60. The stock has a fifty day moving average price of $0.81 and a two-hundred day moving average price of $0.99.

Institutional Investors Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health as of its most recent SEC filing. Institutional investors own 12.04% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.